All Stories

  1. Computational elucidation of stomidazolone mediated inhibition of stomatal differentiation and its implication in plant developmental regulation
  2. Molecular insights into the role of Estrogen Receptor Beta in Ecdysterone Mediated Anabolic Activity
  3. Frontiers in Computational Chemistry: Volume 6
  4. Effects of Smokeless Tobacco Samples from Tabuk Saudi Arabia on Nitric Oxide Production: A Potential Risk for Cancer and Cardiovascular Diseases
  5. Exploiting Dengue Virus Protease as a Therapeutic Target: Current Status, Challenges and Future Avenues
  6. Site-directed Fragnomics and MD Simulations Approaches to Identify Interleukin- 2 Inhibitors
  7. Exploring the Molecular Mechanisms of 17β-HSD5-induced Carcinogenicity of Catha Edulis via Molecular Modeling Approach.
  8. Frontiers in Computational Chemistry: Volume 5
  9. Synthesis of Novel 8-Hydroxyquinoline Derivatives through Mannich Reaction and their Biological Evaluation as Potential Immunomodulatory Agents
  10. Computational Overview of Mycobacterial Thymidine Monophosphate Kinase
  11. Isolation of Cardamonin and Pinostrobin Chalcone from the Rhizomes of Boesenbergia rotunda (L.) Mansf. and their Cytotoxic Effects on H-29 and MDA-MB-231 Cancer Cell Lines
  12. Characterization of cryptic allosteric site at IL-4Rα: New paradigm towards IL-4/IL-4R inhibition
  13. 2-Oxo-1,2,3,4-tetrahydropyrimidines Ethyl Esters as Potent β- Glucuronidase Inhibitors: One-pot Synthesis, In vitro and In silico Studies
  14. Protein kinase A-dependent insulinotropic effect of selected flavonoids
  15. Molecular dynamics simulation of interleukin-2 and its complex and determination of the binding free energy
  16. Catalytic asymmetric synthesis of indole derivatives as novel α -glucosidase inhibitors in vitro
  17. Synthesis, and In Vitro and In Silico α-Glucosidase Inhibitory Studies of 5-Chloro-2-Aryl Benzo[d]thiazoles
  18. Analyzing the Behavior of Neuronal Pathways in Alzheimer's Disease Using Petri Net Modeling Approach
  19. Bioactivity, Safety, and Efficacy of Amphotericin B Nanomicellar Aerosols Using Sodium Deoxycholate Sulfate as the Lipid Carrier
  20. Molecular dynamics simulations reveal structural insights into inhibitor binding modes and mechanism of casein kinase II inhibitors
  21. Computational and biological characterization of fusion proteins of two insecticidal proteins for control of insect pests
  22. Synthesis, antimicrobial activity, pharmacophore modeling and molecular docking studies of new pyrazole-dimedone hybrid architectures
  23. Studies of Flavokawain B Type Chalcones and their Cytotoxic Effects
  24. Structural and Functional Characterization of RNA-binding Site of Rev and Rev-Response-Element RNA Complex via All Atom Molecular Dynamics Simulations
  25. Eriodictyol stimulates insulin secretion through cAMP/PKA signaling pathway in mice islets
  26. 5-Acetyl-6-methyl-4-aryl-3,4-dihydropyrimidin-2(1 H )-ones: As potent urease inhibitors; synthesis, in vitro screening, and molecular modeling study
  27. Pharmacologically Safe Nanomicelles of Amphotericin B With Lipids: Nuclear Magnetic Resonance and Molecular Docking Approach
  28. Synthesis of thiobarbituric acid derivatives: In vitro α -glucosidase inhibition and molecular docking studies
  29. Atom and receptor based 3D QSAR models for generating new conformations from pyrazolopyrimidine as IL-2 inducible tyrosine kinase inhibitors
  30. Reprofiling of full-length phosphonated carbocyclic 2′-oxa-3′-aza-nucleosides toward antiproliferative agents: Synthesis, antiproliferative activity, and molecular docking study
  31. Synthesis, molecular structure, spectral analysis, and biological activity of new malonamide derivatives as α-glucosidase inhibitors
  32. Frontiers in Computational Chemistry
  33. Superoxide scavenging and antiglycation activity of rhinacanthins-rich extract obtained from the leaves of Rhinacanthus nasutus
  34. Interleukin-4 receptor signaling and its binding mechanism: A therapeutic insight from inhibitors tool box
  35. Synthesis of pyrimidine-2,4,6-trione derivatives: Anti-oxidant, anti-cancer, α-glucosidase, β-glucuronidase inhibition and their molecular docking studies
  36. Active site characterization and structure based 3D-QSAR studies on non-redox type 5-lipoxygenase inhibitors
  37. 3D-QSAR Studies on Barbituric Acid Derivatives as Urease Inhibitors and the Effect of Charges on the Quality of a Model
  38. The immunomodulation potential of the synthetic derivatives of benzothiazoles: Implications in immune system disorders through in vitro and in silico studies
  39. In silico based investigation of dynamic variations in neprilysin (NEP and NEP2) proteins for extracting the point of specificity
  40. Synthesis and dynamics studies of barbituric acid derivatives as urease inhibitors
  41. Binding site identification and role of permanent water molecule of PIM-3 kinase: A molecular dynamics study
  42. Structure based 3D-QSAR studies of Interleukin-2 inhibitors: Comparing the quality and predictivity of 3D-QSAR models obtained from different alignment methods and charge calculations
  43. In-silico identification of the binding mode of synthesized adamantyl derivatives inside cholinesterase enzymes
  44. Gd-Complexes of New Arylpiperazinyl Conjugates of DTPA-Bis(amides): Synthesis, Characterization and Magnetic Relaxation Properties
  45. 3D Structure Prediction of Human β1-Adrenergic Receptor via Threading-Based Homology Modeling for Implications in Structure-Based Drug Designing
  46. Design and synthesis of chalcone derivatives as potent tyrosinase inhibitors and their structural activity relationship
  47. Frontiers in Computational Chemistry
  48. Synthesis, Bioactivity, Molecular Docking and POM Analyses of Novel Substituted Thieno[2,3-b]thiophenes and Related Congeners
  49. Human serum albumin-specific recognition of the natural herbal extract of Stryphnodendron polyphyllum through STD NMR, hyphenations and docking simulation studies
  50. Evaluation of binding competition and group epitopes of acetylcholinesterase inhibitors by STD NMR, Tr-NOESY, DOSY and molecular docking: an old approach but new findings
  51. CoMFA and CoMSIA studies on a series of fluroquinolone derivatives for potential anti-inflammatory activity
  52. Synthesis, Anti-microbial and Molecular Docking Studies of Quinazolin-4(3H)-one Derivatives
  53. Design of New and Potent Diethyl Thiobarbiturates as Urease Inhibitors: A Computational Approach
  54. Structure-based design, synthesis and biological evaluation of β-glucuronidase inhibitors
  55. Structure-based 3D-QSAR studies on quinazoline derivatives as platelets-derived growth factor (PDGFR) inhibitors
  56. In Silico Identification and Evaluation of Leads for the Simultaneous Inhibition of Protease and Helicase Activities of HCV NS3/4A Protease Using Complex Based Pharmacophore Mapping and Virtual Screening
  57. First ComprehensiveIn SilicoAnalysis of the Functional and Structural Consequences of SNPs in HumanGalNAc-T1Gene
  58. Structural Basis of Binding and Rationale for the Potent Urease Inhibitory Activity of Biscoumarins
  59. The exploration of interaction studies of smaller size, mostly ignored yet intrinsically inestimable molecules towards BSA; An example of STD and DOSY NMR
  60. Molecular docking- and genetic algorithm-based approaches to produce robust 3D-QSAR models
  61. Bioisosteric approach in designing new monastrol derivatives: An investigation on their ADMET prediction using in silico derived parameters
  62. Brine shrimp lethality assay ‘an effective prescreen’: Microwave-assisted synthesis, BSL toxicity and 3DQSAR studies-based designing, docking and antitumor evaluation of potent chalcones
  63. Structure based virtual screening-driven identification of monastrol as a potent urease inhibitor
  64. In-Silico Analysis of Chromone Containing Sulfonamide Derivatives as Human Carbonic Anhydrase Inhibitors
  65. Identification of novel Interleukin-2 inhibitors through computational approaches
  66. In vitro and in silico exploration of IL-2 inhibition by small drug-like molecules
  67. Crude to leads: a triple-pronged direct NMR approach in coordination with docking simulation
  68. A combined 3D-QSAR and docking studies for the In-silico prediction of HIV-protease inhibitors
  69. In-vitro immunomodulatory and anti-cancerous activities of biotransformed products of Dianabol through Azadirachta indica and its molecular docking studies
  70. Molecular docking simulation studies on potent butyrylcholinesterase inhibitors obtained from microbial transformation of dihydrotestosterone
  71. Development of robust QSAR model using rapid overlay of crystal structures (ROCS) based alignment: a test case of Tubulin inhibitors
  72. A combined 3D-QSAR and molecular docking strategy to understand the binding mechanism of V600EB-RAF inhibitors
  73. Erratum to: Three-dimensional quantitative structure–activity relationship (CoMSIA) analysis of bis-coumerine analogues as urease inhibitors
  74. Combined Pharmacophore and 3D-QSAR Study on A Series of Staphylococcus aureus Sortase A inhibitors
  75. Structure-based 3D-QSAR models and dynamics analysis of novel N-benzyl pyridinone as p38α MAP kinase inhibitors for anticytokine activity
  76. Synthesis, biological evaluation, and molecular docking studies of benzyl, alkyl and glycosyl [2-(arylamino)-4,4-dimethyl-6-oxo-cyclohex-1-ene]carbodithioates, as potential immunomodulatory and immunosuppressive agents
  77. Three-dimensional quantitative structure–activity relationship (CoMSIA) analysis of bis-coumerine analogues as urease inhibitors
  78. A Novel Pharmacophore Model to Identify Leads for Simultaneous Inhibition of Anti-coagulation and Anti-inflammatory Activities of Snake Venom Phospholipase A2
  79. In Silico and In Vitro Immunomodulatory Studies on Compounds of Lindelofia stylosa
  80. Dynamic changes in the secondary structure of ECE-1 and XCE account for their different substrate specificities
  81. 3D-QSPR Method of Computational Technique Applied on Red Reactive Dyes by Using CoMFA Strategy
  82. Molecular modeling-based antioxidant arylidene barbiturates as urease inhibitors
  83. In silico studies on 2,3-dihydro-1,5-benzothiazepines as cholinesterase inhibitors
  84. Optimization of Structure Based Virtual Screening Protocols Against Thymidine Monophosphate Kinase Inhibitors as Antitubercular Agents
  85. Synthesis and QSAR analysis of chalcone derivatives as nitric oxide inhibitory agent
  86. Synthesis of novel inhibitors of β-glucuronidase based on benzothiazole skeleton and study of their binding affinity by molecular docking
  87. Molecular docking studies of potent inhibitors of tyrosinase and α-glucosidase
  88. Molecular dynamics simulation of mammalian 15S-lipoxygenase with AMBER force field
  89. Ligand-Based 3D-QSAR Studies of Diaryl Acyl-sulfonamide Analogues as Human Umbilical Vein Endothelial Cells Inhibitors Stimulated by VEGF
  90. Molecular and structural determinants of adamantyl susceptibility to HLA-DRs allelic variants: an in silico approach to understand the mechanism of MLEs
  91. Synthesis, antioxidant activities and urease inhibition of some new 1,2,4-triazole and 1,3,4-thiadiazole derivatives
  92. Docking and 3D-QSAR modeling of cyclin-dependent kinase 5/p25 inhibitors
  93. Identification of Novel Urease Inhibitors by High-Throughput Virtual and in Vitro Screening
  94. Benchmarking docking and scoring protocol for the identification of potential acetylcholinesterase inhibitors
  95. Identification of potent urease inhibitors via ligand- and structure-based virtual screening and in vitro assays
  96. Synthesis and biological activity of oxadiazole and triazolothiadiazole derivatives as tyrosinase inhibitors
  97. Classical and QM/MM MD simulations of sodium(I) and potassium(I) ions in aqueous solution
  98. Immunosuppressive Activity of Buxidin andE-Buxenone fromBuxus hyrcana
  99. In silico modeling of the specific inhibitory potential of thiophene-2,3-dihydro-1,5-benzothiazepine against BChE in the formation of β-amyloid plaques associated with Alzheimer's disease
  100. Template-based structure prediction and molecular dynamics simulation study of two mammalian Aspartyl-tRNA synthetases
  101. Ligand-based 3D-QSAR Studies of Physostigmine Analogues as Acetylcholinesterase Inhibitors
  102. Molecular dynamics simulation of Axillaridine–A: A potent natural cholinesterase inhibitor
  103. Prediction of Binding Affinities for Hydroxamic Acid Derivatives as Urease Inhibitors by Molecular Docking and 3D-QSAR Studies
  104. An investigation of the kinetic and anti-angiogenic properties of plant glycoside inhibitors of thymidine phosphorylase
  105. Receptor-Based 3D-QSAR Study for Recognizing True Binding Mode of Mercaptoacyldipeptides at the Active Site of Neutral Endopeptidase
  106. CoMFA and CoMSIA 3D-QSAR analysis on hydroxamic acid derivatives as urease inhibitors
  107. In silicostudies of urease inhibitors to explore ligand-enzyme interactions
  108. Receptor-Based Modeling and 3D-QSAR for a Quantitative Production of the Butyrylcholinesterase Inhibitors Based on Genetic Algorithm
  109. 3D-QSAR CoMFA studies on bis-coumarine analogues as urease inhibitors: A strategic design in anti-urease agents
  110. Family 18 chitolectins: Comparison of MGP40 and HUMGP39
  111. Successful computer guided planned synthesis of (4R)-thiazolidine carboxylic acid and its 2-substituted analogues as urease inhibitors
  112. Biological and molecular docking studies on coagulin-H: Human IL-2 novel natural inhibitor
  113. Withanolides, a new class of natural cholinesterase inhibitors with calcium antagonistic properties
  114. Juliflorine: A potent natural peripheral anionic-site-binding inhibitor of acetylcholinesterase with calcium-channel blocking potential, a leading candidate for Alzheimer’s disease therapy
  115. Presence of Antispasmodic, Antidiarrheal, Antisecretory, Calcium Antagonist and Acetylcholinesterase Inhibitory Steroidal Alkaloids inSarcococca saligna
  116. Cholinesterase inhibitory and spasmolytic potential of steroidal alkaloids
  117. New pregnane-type steroidal alkaloids from Sarcococca saligna and their cholinesterase inhibitory activity
  118. Kinetics and structure–activity relationship studies on pregnane-type steroidal alkaloids that inhibit cholinesterases
  119. New Cholinesterase-Inhibiting Steroidal Alkaloids fromSarcococca saligna
  120. 3D-QSAR Studies on natural acetylcholinesterase inhibitors of Sarcococca saligna by comparative molecular field analysis (CoMFA)
  121. Molecular Docking Studies of Natural Cholinesterase-Inhibiting Steroidal Alkaloids fromSarcococcasaligna
  122. New Steroidal Alkaloids FromSarcococca Saligna
  123. Pregnane-Type Steroidal Alkaloids ofSarcococca saligna: a New Class of Cholinesterase Inhibitors